email@email.com
Request a Call
Contact Online
Subscribe |
| Log In
The most widely read newsletter on China's life science industry.
Toggle navigation
Home
Subscribe
Top Stories
Hot Topics
Search
Conferences
Consulting
About Us
Contact Us
You are here:
All Products
Articles
Instant access to selected
ChinaBio® Today
subscriber-only articles.
Browse
All Products
Articles
Viewing
1366 - 1380
of 3630 products
View All
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
Next
Porton Biologics Raises $61 Million for Cell/Gene Therapy CDMO Services
$5.00
Available
PhageLux AgriHealth Acquires New China Manufacturing Site
$5.00
Available
Qilu In-Licenses Preclinical ADC Candidate from Korea's Peptron
$5.00
Available
Kintor Starts China Trials of Topical Androgen Receptor Inhibitor
$5.00
Available
Ocumension Acquires Implant Therapy for Retina Diseases in $119 Million Deal
$5.00
Available
SciNeuro In-Licenses China Rights to Lilly Treatment for Parkinson's
$5.00
Available
StoneWise Raises $100 Million to Support AI Drug Development Services
$5.00
Available
BDgene Completes $9 Million Round for CRISPR/Cas9 mRNA Candidates
$5.00
Available
Innovent Reports Positive Data from Phase III Tyvyt Trial in NSCLC
$5.00
Available
LintonPharm Starts China Trial of Candidate for Bladder Cancer
$5.00
Available
Junshi's PD-1 Approved for Third Indication in China, Bladder Cancer
$5.00
Available
Gracell Reports Positive Data from Trial of Off-the Shelf CAR-T Candidate
$5.00
Available
Shanghai NewMed Medical Raises $100 Million for Heart Repair Devices
$5.00
Available
HutchMed Raises $100 Million in Private Placement for Oncology Portfolio
$5.00
Available
Biogen Acquires Rights to Bio-Thera RA Biosimilar for $30 Million Upfront
$5.00
Available